openPR Logo
Press release

Cystinosis Pipeline Insight Report 2023: Clinical Trials 2023 (Updates), FDA Approvals, Therapies, Treatment Market and Companies working by DelveInsight | BioCryst Pharmaceuticals, Bavarian Nordic, Flow Pharma, Public Health Vaccines and Others

08-30-2023 06:06 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Cystinosis pipeline

Cystinosis pipeline

(New York, USA) DelveInsight's 'Cystinosis Pipeline Insight 2023' report provides comprehensive global coverage of available, marketed, and pipeline Cystinosis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Cystinosis pipeline domain.

Request for Cystinosis sample pages @ https://www.delveinsight.com/report-store/cystinosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key Takeaways from the Cystinosis Pipeline Report
• Over 5+ Cystinosis pipeline therapies are in various stages of development, and their anticipated acceptance in the Cystinosis market would significantly increase market revenue.
• Leading Cystinosis companies developing novel drug candidates to improve the Cystinosis treatment landscape include Avrobio, Inc., Gilead, Mylan N.V., Novartis AG, Orizon Pharma Plc, Nacuity Pharmaceuticals, and others.
• Promising Cystinosis pipeline therapies in various stages of development include AVR RD 04, NP-3, and others.

Request for free sample pages @ https://www.delveinsight.com/sample-request/cystinosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cystinosis Overview
Cystinosis is a rare, inherited metabolic disorder characterized by the accumulation of the amino acid cystine within cells due to a defective transport protein. This leads to the formation of crystals that can damage various organs, especially the kidneys and eyes. There are three main forms of cystinosis: infantile, juvenile, and adult-onset. Infantile cystinosis is the most severe and typically manifests within the first year of life, causing kidney dysfunction, growth retardation, and potentially fatal complications. Juvenile and adult-onset forms have milder symptoms that may include kidney dysfunction, muscle weakness, and vision problems. Treatment primarily involves managing symptoms and reducing cystine levels with medications like cysteamine, as well as kidney transplantation in severe cases. Ongoing research aims to develop better therapies to alleviate the impact of this debilitating genetic disorder.

Cystinosis Pipeline Analysis: Drug Profile
AVR RD 04: AVROBIO
AVROBIO's investigational gene therapy for cystinosis is being studied in a Phase 1/2 investigational trial sponsored by the University of California, San Diego. The first patient was dosed in October 2019. The single-arm trial is expected to enroll four adults and a potential follow-on cohort of two adults or adolescents at least 14 years of age who are currently being treated with cysteamine, the standard of care for cystinosis.

Discover more about the emerging Cystinosis drugs @ https://www.delveinsight.com/sample-request/cystinosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Cystinosis Pipeline Therapeutics Assessment
• By development stage
• By product type
• By route of administration
• By molecule type
• By MOA type

Scope of the Cystinosis Pipeline Report
• Coverage: Global
• Key Cystinosis Companies: Avrobio, Inc., Gilead, Mylan N.V., Novartis AG, Orizon Pharma Plc, Nacuity Pharmaceuticals, and others
• Key Cystinosis Pipeline Therapies: AVR RD 04, NP-3, and others

Find out more about the Cystinosis treatment options in development @ https://www.delveinsight.com/sample-request/cystinosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Introduction
2. Executive Summary
3. Cystinosis Overview
4. Cystinosis Pipeline Therapeutics
5. Late-Stage Products (Phase III)
6. Mid-Stage Products (Phase II)
7. Early Stage Products (Phase I/II)
8. Cystinosis Preclinical Stage Products
9. Discovery Stage Products
10. Cystinosis Therapeutic Assessment
11. Inactive Cystinosis Products
12. Collaborations Assessment- Licensing / Partnering / Funding
13. Cystinosis Unmet Needs
14. Cystinosis Market Drivers and Barriers
15. Appendix
16. About DelveInsight

Trending Report:
• Acute Pharyngitis Market: https://www.delveinsight.com/report-store/acute-pharyngitis-market
• Bartonellosis Market: https://www.delveinsight.com/report-store/bartonellosis-market
• Concussions Market Size: https://www.delveinsight.com/report-store/concussions-market
• Allergic Rhinoconjunctivitis Market: https://www.delveinsight.com/report-store/allergic-rhinoconjunctivitis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Heavy Metal Poisoning Markets: https://www.delveinsight.com/report-store/heavy-metal-poisoning-market
• Nipah Virus Infection Market: https://www.delveinsight.com/report-store/nipah-virus-niv-infection-market
• Central Venous Catheters Market: https://www.delveinsight.com/report-store/central-venous-catheters-market
• Encephalitis Market: https://www.delveinsight.com/report-store/encephalitis-market
• Vertigo Market: https://www.delveinsight.com/report-store/vertigo-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Bipolar Depression Market: https://www.delveinsight.com/report-store/bipolar-disorder-manic-depression-market
• Rett Syndrome Market: https://www.delveinsight.com/report-store/rett-syndrome-market
• Central Serous Chorioretinopathy Market: https://www.delveinsight.com/report-store/central-serous-chorioretinopathy-market
• Prosthetic Joint Infection Market: https://www.delveinsight.com/report-store/prosthetic-joint-infection-market
• Calciphylaxis Market: https://www.delveinsight.com/report-store/calciphylaxis-market
• Metastatic Bone Pain Market: https://www.delveinsight.com/report-store/metastatic-bone-pain-market
• Postsurgical Pain Market: https://www.delveinsight.com/report-store/postoperative-pain-market
• Acute Ocular Pain Market: https://www.delveinsight.com/report-store/acute-ocular-pain-market
• Bacteremia Market: https://www.delveinsight.com/report-store/bacteremia-market
• Cardiopulmonary Bypass Equipment Market: https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market
• Chronic Pain Associated With Painful Diabetic Neuropathy Market: https://www.delveinsight.com/report-store/chronic-pain-associated-with-painful-diabetic-neuropathy-market
• Generalized Pustular Psoriasis Market: https://www.delveinsight.com/report-store/generalized-pustular-psoriasis-market
• Parkinsons Disease Related Dementia Market: https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market
• Polypoidal Choroidal Vasculopathy Market: https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market
• Progressive Familial Intrahepatic Cholestasis Market: https://www.delveinsight.com/report-store/progressive-familial-intrahepatic-cholestasis-pfic-market
• Waiha Market: https://www.delveinsight.com/report-store/warm-autoimmune-hemolytic-anemia-waiha-market
• Atypical Hemolytic Uremic Syndrome Ahus Market: https://www.delveinsight.com/report-store/atypical-hemolytic-uremic-syndrome-ahus-market
• Egfr Non-small Cell Lung Cancer Market: https://www.delveinsight.com/report-store/epidermal-growth-factor-receptor-non-small-cell-lung-cancer-market
• Reactive Arthritis Market: https://www.delveinsight.com/report-store/reactive-arthritis-market
• Central Retinal Venous Occulsion Market: https://www.delveinsight.com/report-store/central-retinal-venous-occulsion-market
• Age Related Vision Dysfunction Market: https://www.delveinsight.com/report-store/age-related-vision-dysfunction-market
• Atopic Keratoconjunctivitis Akc Market: https://www.delveinsight.com/report-store/atopic-keratoconjunctivitis-market
• Hyperinsulinemic Hypoglycemia Market: https://www.delveinsight.com/report-store/congenital-hyperinsulinism-market
• Thyroid Eye Disease Market: https://www.delveinsight.com/report-store/thyroid-eye-disease-market
• Diffuse Cutaneous Systemic Sclerosis Market: https://www.delveinsight.com/report-store/diffuse-cutaneous-systemic-sclerosis-dcssc-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Acrocallosal Syndrome Market: https://www.delveinsight.com/report-store/acrocallosal-syndrome-market
• Treatment Resistant Depression Market: https://www.delveinsight.com/report-store/treatment-resistant-depression-trd-market
• Catheter-related Bloodstream Infections Market: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market
• Absssi Market: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/food-allergy-market-insights
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market

Contact Us
Ankit Nigam
info@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cystinosis Pipeline Insight Report 2023: Clinical Trials 2023 (Updates), FDA Approvals, Therapies, Treatment Market and Companies working by DelveInsight | BioCryst Pharmaceuticals, Bavarian Nordic, Flow Pharma, Public Health Vaccines and Others here

News-ID: 3187681 • Views:

More Releases from DelveInsight Business Research

Gastric Cancer Market to Exceed USD 700 Million in HER2+ Segment by 2034 Across 7MM, Backed by 211,550 Annual Cases and 15+ Key Therapies | DelveInsight
Gastric Cancer Market to Exceed USD 700 Million in HER2+ Segment by 2034 Across …
Gastric cancer is the fifth most common malignancy worldwide, with incidence varying by region and highest rates reported in Eastern Asia and Eastern Europe. Japan records the highest burden among the 7MM, with about 129,500 cases in 2024. Many patients, particularly in Western countries, are diagnosed at advanced (Stage IV) stages, while Japan detects more cases early (Stage I). In the US, around 35% present with metastatic disease at diagnosis,
Myelofibrosis Market to Double by 2034, Surpassing USD 5.6 Billion Across 7MM with 9% CAGR Growth, states DelveInsight
Myelofibrosis Market to Double by 2034, Surpassing USD 5.6 Billion Across 7MM wi …
The Myelofibrosis market across the seven major markets (7MM) is anticipated to experience significant growth, rising from approximately USD 2,602 million in 2025 to nearly USD 5,638 million by 2034, reflecting a compound annual growth rate (CAGR) of about 9% during the forecast period. In 2024, the market was valued at around USD 2.2 billion, with the United States leading at nearly USD 1.7 billion, far surpassing the EU4, the United
Triple-Negative Breast Cancer Clinical Trial Landscape Expands With 170+ Pipeline Assets, According to DelveInsight
Triple-Negative Breast Cancer Clinical Trial Landscape Expands With 170+ Pipelin …
An expanding portfolio of novel therapies for triple-negative breast cancer (TNBC) including TECENTRIQ (Hoffmann-La Roche), IPI-549 (Infinity Pharmaceuticals), Leronlimab (CytoDyn), MDNA11 (Medicenna Therapeutics), VIP236 (Vincerx Pharma), and CFI-400945 (Treadwell Therapeutics) is anticipated to significantly influence market expansion and transform the TNBC treatment landscape. DelveInsight's Triple Negative Breast Cancer Pipeline Insight report offers an extensive evaluation of more than 165 companies and over 170 therapeutic candidates advancing through the TNBC pipeline. The
Asthma Market to Witness Steady Growth Through 2034 Driven by Novel Biologics and Triple-Combination Therapies | DelveInsight
Asthma Market to Witness Steady Growth Through 2034 Driven by Novel Biologics an …
DelveInsight's latest Asthma Market Insights, Epidemiology, and Market Forecast - 2034 report provides an in-depth evaluation of current treatment practices, emerging asthma drugs, market share of individual therapies, and forecasted market trends across the seven major markets (7MM) - the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The asthma market is expected to experience sustained growth over the next decade, supported by the launch of

All 5 Releases


More Releases for Market:

Sorbitol Market Forecast, Sorbitol Market Analysis, Sorbitol Market Growth, Sorb …
The Sorbitol Market has been fragmented based on the productivity of several companies; therefore, each segment and its sub-segments are analyzed in the research report. Furthermore, the report offers 360 views on historical and upcoming growth based on volume, value, production, and consumption. Moreover, it classifies depend on sub-segments, key segments as per the significant regions and offers an in-depth analysis on the competitive edge of the market. This report
Esterquats Market, Esterquats Market Size, Esterquats Market Share, Esterquats M …
The "Esterquats Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside political,
Syringe and Needle Market Size, Market Share, Market Trends, Market Analysis, Ma …
Market Overview: The global syringe and needle market is a critical component of the healthcare industry, serving as indispensable tools for administering medications, vaccines, and drawing blood samples. This market is characterized by a diverse range of products catering to various medical needs, including disposable syringes, safety syringes, insulin syringes, hypodermic needles, and more. This article provides an in-depth analysis of the syringe and needle market, focusing on its market overview,
India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned? In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth
India Payment Services Market, Industry, Market Revenue, Market Sales, Market Sh …
Overview of India Payment Service Market India payment services market, which has traditionally been dominated by cash, witnessed advancement towards digital transactions both in terms of value and volume during the demonetization phase in India. The total market size for the India Payment service market has raised from INR ~ trillion in FY’16 to INR ~ trillion in FY21, during the review period. Regulatory authorities such as the Reserve Bank of
Global Optical Interconnects Market, Market Size, Market Shares, Market Growth A …
In integrated circuits, optical interconnects majorly refers to a system of transmitting signals from one fragment of an integrated circuit to another part which is using light. Optical interconnects have been in high demand due to the high latency and power consumption incurred by conventional metal interconnects in conveying electrical signals over long distances, such as in interconnects classed as global interconnects. The International Technology Roadmap for Semiconductors (ITRS) has emphasized